personalized medicines

Study discovers why leading gout medication is ineffective for many

Tue Jul 14, 2015

Spiked rods of uric acid crystals from synovial fluid photographed under a microscope with polarized light. In patients with gout, such crystals can accumulate in the joints, causing pain and inflammation.

Allopurinol, the first-choice medication for treating gout—an excruciatingly painful condition that is the most common form of inflammatory arthritis, afflicts more than eight million Americans, and is on the rise worldwide—is not fully effective in more than half of patients.

Reflection: 30 years of top NIH funding for UCSF School of Pharmacy

Wed Dec 22, 2010

Kathy Giacomini, PhD (center), co-chair of the Department of Bioengineering and Therapeutic Sciences, discusses research results in the lab with postdocs Sook Wah Yee (left), and Amber Dahlin (right).

Table of contents

Introduction
Budget significance
Reasons for past success
A decade of funding for bioinformatics
New drug discovery directions attract support

Genetic ancestry proven powerful in predicting lung function

Thu Jul 8, 2010

Crowd down Stockton street: niallkennedy

Genetic ancestry can tell more about a person's potential lung function than the self-identified racial profile commonly used to determine normal lung function reference standards, according to the results of research led by UCSF and Northwestern University.

Burchard comments on asthma genetics

Thu Apr 29, 2010

Esteban G. Burchard, MD, MPH

Asthma specialist and genetics researcher, Esteban G.

Pharmacogenomics research spans school agenda

Mon Feb 9, 2009

Pharmacogenomics research at the UCSF School of Pharmacy extends from a better understanding of information derived from the Human Genome Project to research on specific genetic differences in humans and how they might affect an individual's response to a medication.

Benet receives Magic Bullet Lifetime Achievement Award

Mon Dec 15, 2008

Leslie Z.

Phillips awarded $5 Million NCI grant to study personalized medicine

Mon Oct 13, 2008

The wider world use of medical tests and treatments based on individual genetic differences is the focus of a new, US$5 million research program funded by the National Cancer Institute (NCI) and led by UCSF School of Pharmacy health economist Kathryn Phillips,

Burchard explores asthma risk in Latinos

Wed Nov 21, 2007

What began as a fascination with fish when he was a child eventually led Esteban Burchard, MD to study genetic differences behind asthma risk.

Topics and Expertise: personalized medicines